Lincoln Pharmaceuticals Ltd.
585.00-2.3 (-0.39%)
24 Jul, 12:00 AM
Annual Reports and Financial Documents
Lincoln Pharmaceuticals Ltd. annual reports, quarterly results, earnings call transcripts and investor presentations. All official filings in one place.
Corporate Announcements and Regulatory Filings
Lincoln Pharmaceuticals Ltd. BSE/NSE disclosures, board meeting outcomes, insider trading notifications, acquisitions and other regulatory filings.
- Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018Pursuant to provision of Regulation 74(5) of SEBI (Depository and Participants) Regulation, 2018, we hereby submit the confirmation certificate received from MUFG Intime India Private Limited, ....
- Board Meeting Intimation for Consideration Of Audited (Standalone & Consolidated) Financial Results Of The Company For The Quarter And Year Ended On March 31, 2026.Lincoln Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/05/2026 ,inter alia, to consider and approve Audited (standalone ....
- Format of the Annual Disclosure to be made by an entity identified as a LC - Annexure B2<b>Format of the Annual Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=''1px''> <tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> ....
- Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A16 Apr 2026Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A<b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=''1px''><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> ....
- Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018Pursuant to Provision of Regulation 74(5) of SEBI (Depository and Participants) Regulation, 2018, We hereby submit the confirmation Certificate received from MUFG Intime India Private Limited, ....
- Board Meeting Intimation for Consideration And Approval Of Unaudited Financial Results (Standalone And Consolidated) Of The Company For The Third Quarter And Nine Months Ended 31St December, 2025.Lincoln Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/02/2026 ,inter alia, to consider and approve unaudited Financial ....
- Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018Pursuant to provision of Regulation 74(5) of SEBI (Depository and Participants) Regulation, 2018, we hereby submit the confirmation certificate received from MUFG Intime India Private Limited, ....
Frequently Asked Questions
Where can I download the annual report of Lincoln Pharmaceuticals Ltd.?
Annual reports of Lincoln Pharmaceuticals Ltd. are available for download in the Annual Reports and Financial Documents section of the Resources tab, organised by financial year.
Where can I find the quarterly results of Lincoln Pharmaceuticals Ltd.?
Quarterly earnings results and presentations of Lincoln Pharmaceuticals Ltd. are available in the Annual Reports and Financial Documents section of the Resources tab. Detailed financials are also in the Statements tab.
Does Lincoln Pharmaceuticals Ltd. publish earnings call transcripts?
Earnings call transcripts of Lincoln Pharmaceuticals Ltd., where available, are listed in the Annual Reports and Financial Documents section of the Resources tab.
Where can I find investor presentations of Lincoln Pharmaceuticals Ltd.?
Investor presentations and annual day presentations of Lincoln Pharmaceuticals Ltd. are listed in the Resources tab under Annual Reports and Financial Documents.
What are the recent corporate announcements of Lincoln Pharmaceuticals Ltd.?
Corporate announcements and regulatory filings of Lincoln Pharmaceuticals Ltd. as submitted to BSE and NSE are available in the Corporate Announcements and Regulatory Filings section of the Resources tab.
How do I access the regulatory filings of Lincoln Pharmaceuticals Ltd.?
Regulatory filings including board meeting outcomes, insider trading disclosures and other exchange notifications of Lincoln Pharmaceuticals Ltd. are in the Corporate Announcements and Regulatory Filings section of the Resources tab.
What is the ISIN of Lincoln Pharmaceuticals Ltd.?
The ISIN (International Securities Identification Number) of Lincoln Pharmaceuticals Ltd. is INE405C01035. This is the unique identifier used across exchanges and depositories.
On which stock exchange is Lincoln Pharmaceuticals Ltd. listed?
Lincoln Pharmaceuticals Ltd. is listed on NSE and BSE. The NSE symbol is LINCOLN and the BSE code is -.
Where can I find the shareholding pattern of Lincoln Pharmaceuticals Ltd.?
The quarterly shareholding pattern of Lincoln Pharmaceuticals Ltd. showing promoter, FII, DII, mutual fund and public holdings is available in the Shareholding Pattern section on the Overview tab.
How current is the data for Lincoln Pharmaceuticals Ltd. on Sharpely?
Share price data for Lincoln Pharmaceuticals Ltd. is updated as of 24 Jul 2026. Financial statements, shareholding and other fundamental data are updated after each quarterly disclosure.